-
April 23: The Week in Cancer NewsAnti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment, and the FDA approves an immunotherapy drug for endometrial cancer
by Marci A. Landsmann
-
How Long Do Immunotherapy Side Effects Last?For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.
by Anna Goshua
-
Chemobrain: It’s Not Your ImaginationScientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
by Marci A. Landsmann
-
Are You a Candidate for Immunotherapy?Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.
by Kendall K. Morgan
-
Searching the Blood for Signs of Altered ImmunityThe immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
-
A Fast Track for Cancer VaccinesThe rapid development of mRNA COVID-19 vaccines could spark advances in similar treatments for cancer.
by Stephen Ornes
-
Hope for Cancer Health EquityHealth care providers and communities are making strides toward ensuring equity in cancer treatment.
by Marci A. Landsmann
-
Cancer Care’s Virtual RevolutionThe pandemic has made telehealth a necessity for many cancer patients. When the crisis clears, these technological tools may improve cancer care in the long term.
by Stephen Ornes
-
March 26: The Week in Cancer NewsUnderrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and a study provides new insight into how melanoma metastasizes.
by Bradley Jones
-
From the Editor-in-Chief
Cancer in Adolescents and Young AdultsPatients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.
by William G. Nelson, MD, PhD
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
